Clinical Trials Logo

Clinical Trial Summary

The purpose of this evaluation is to receive the greatest benefit of new custom made hearing product technology and shell modification for the end customer and to continual improve the custom made hearing products.


Clinical Trial Description

This is a controlled, single blinded comparative study which is conducted monocentric at Phonak Headquarters in Staefa.

The purpose of the studies is to evaluate the strengths and weaknesses of new custom product development in comparison to existing/old products. The results should promote the custom product development, to provide a maximum of benefit and wearing comfort to the hearing aid user. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02545569
Study type Interventional
Source Phonak AG, Switzerland
Contact Jana-Kosima Schwarzlos, B.Sc.
Phone +41 58 928 0101
Email JanaKosima.Schwarzlos@sonova.com
Status Not yet recruiting
Phase N/A
Start date January 6, 2020
Completion date December 2020

See also
  Status Clinical Trial Phase
Completed NCT02298452 - Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids N/A